Clinical Study of Cannabidiol in Children and Adolescents With Fragile X Syndrome
Condition: Fragile X Syndrome Interventions: Drug: ZYN002 - CBD transdermal gel; Drug: Placebo Sponsor: Zynerba Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials